Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2017050833860N1Phase 3Completed
Phase 3 trial of dexmedetomidine in Forearm Fracture, sponsored by Kashan University of Medical Sciences. Primary endpoints: Intraoperative hemodynamic changes and Postoperative pain. Started Jul 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2017050833860N1.